The role of HDGF in tumor angiogenesis

The role of HDGF in tumor angiogenesis


arigo is proud to announce that our HDGF ELISA Kit (ARG81356) was used for studying tumor angiogenesis and cited in Oncology Reports.

Hepatoma-derived growth factor (HDGF) is a heparin-binding growth factor involved in proliferation, differentiation, and angiogenesis. Overexpression of HDGF is found in multiple cancers. Eguchi and Wakabayashi reported that HDGF enhances VEGF-dependent angiogenesis and FGF2 (bFGF) induces VEGF-independent angiogenesis in NSCLC cells. Their result indicates a cancer treatment option by targeting HDGF.  arigo offers excellent ELISA kit and antibodies to facilitate the research of HDGF and tumor angiogenesis.



Human HDGF ELISA Kit (ARG81356)
Sensitivity: ~ 30 pg/ml
Sample: Serum, plasma, cell culture supernatant

HDGF antibody [SQab1746] (ARG66283)
Reactivity: Hu, Ms, Rat
Application: ELISA, FACS, ICC/IF, IHC, WB


● Angiogenic factors

ELISA Kit Human Mouse
VEGF ARG80124 ARG80207
BDGF ARG81251 ARG82007
bFGF ARG80141 ARG81276
PDGF-BB ARG80166 ARG81250
PlGF ARG80142  
Osteopontin ARG81268 ARG81668


Reference: Eguchi and Wakabayashi (2020) Oncol Rep. 44(1):14-28.


Related articles
Angiogenesis & MVD Antibody Panels are released
The most sensitive human HDGF ELISA kit